CLINICAL RESEARCH: HEART FAILURE
Cardiac Resynchronization Therapy Improves Heart Rate Profile and Heart Rate Variability of Patients With Moderate to Severe Heart Failure
Cecilia Fantoni, MD*, ,
Santi Raffa, MD*,
Francois Regoli, MD*,
Francesco Giraldi, MD ,
Maria Teresa La Rovere, MD ,
John Prentice, PhD||,
Francesca Pastori, MD*,
Simona Fratini, MD, PhD*,
Jorge A. Salerno-Uriarte, MD,
Helmut U. Klein, MD* and
Angelo Auricchio, MD, PhD*,*
* Division of Cardiology, University Hospital, Magdeburg, Germany
Department of Cardiovascular Sciences, University of Insubria, Varese, Italy
Centro Cardiologico Monzino, Milan, Italy
Department of Cardiology, Centro Medico di Montescano, S. Maugeri Foundation, IRCSS, Pavia, Italy
|| Wild Rose Biophysics, Boulder, Colorado.
Manuscript received March 1, 2005;
revised manuscript received May 8, 2005,
accepted June 6, 2005.
* Reprint requests and correspondence: Dr. Angelo Auricchio, Division of Cardiology, University Hospital, Leipzigerstr. 44, D-39120 Magdeburg, Germany. (Email: angelo.auricchio{at}medizin.uni-magdeburg.de).
OBJECTIVES: This study sought to report long-term changes of cardiac autonomic control by continuous, device-based monitoring of the standard deviation of the averages of intrinsic intervals in the 288 five-min segments of a day (SDANN) and of heart rate (HR) profile in heart failure (HF) patients treated with cardiac resynchronization therapy (CRT).
BACKGROUND: Data on long-term changes of time-domain parameters of heart rate variability (HRV) and of HR in highly symptomatic HF patients treated with CRT are lacking.
METHODS: Stored data were retrieved for 113 HF patients (New York Heart Association functional class III to IV, left ventricular ejection fraction  35%, QRS >120 ms) receiving a CRT device capable of continuous assessment of HRV and HR profile.
RESULTS: The CRT induced a reduction of minimum HR (from 63 ± 9 beats/min to 58 ± 7 beats/min, p < 0.001) and mean HR (from 76 ± 10 beats/min to 72 ± 8 beats/min, p < 0.01) and an increase of SDANN (from 69 ± 23 ms to 93 ± 27 ms, p < 0.001) at three-month follow-up, which were consistent with improvement of functional capacity and structural changes. Different kinetics were observed among these parameters. The SDANN reached the plateau before minimum HR, and mean HR was the slowest parameter to change. Suboptimal left ventricular lead position was associated with no significant functional and structural improvement as well as no change or even worsening of HRV. The two-year event-free survival rate was significantly lower (62% vs. 94%, p < 0.005) in patients without any SDANN change ( change 0%) compared with patients who showed an increase in SDANN ( change >0%) four weeks after CRT initiation.
CONCLUSIONS: Cardiac resynchronization therapy is able to significantly modify the sympathetic-parasympathetic interaction to the heart, as defined by HR profile and HRV. Lack of HRV improvement four weeks after CRT identifies patients at higher risk for major cardiovascular events.
|
Abbreviations and Acronyms
| | CRT = cardiac resynchronization therapy | | CRT-D = cardiac resynchronization therapy device with defibrillator back-up | | HF = heart failure | | HR = heart rate | | HRV = heart rate variability | | SDANN = standard deviation of the averages of intrinsic intervals in the 288 five-min segments of a day | | SDNN = standard deviation of RR intervals |
|
This article has been cited by other articles:
|
|
|
|
 
A. Auricchio
Is it time to start with device-based prognosticators?
Europace,
October 6, 2009;
(2009)
eup291v1.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Stahlberg, M. Damgaard, P. Norsk, A. Gabrielsen, A. Sahlen, C. Linde, and F. Braunschweig
Cardiac output response to changes of the atrioventricular delay in different body positions and during exercise in patients receiving cardiac resynchronization therapy
Europace,
September 1, 2009;
11(9):
1160 - 1167.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Landolina, M. Gasparini, M. Lunati, M. Santini, R. Rordorf, A. Vincenti, P. Diotallevi, A. S. Montenero, C. Bonanno, T. De Santo, et al.
Heart rate variability monitored by the implanted device predicts response to CRT and long-term clinical outcome in patients with advanced heart failure
Eur J Heart Fail,
November 1, 2008;
10(11):
1073 - 1079.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Braunschweig, I. Ford, V. Conraads, M. R. Cowie, G. Jondeau, J. Kautzner, M. Lunati, R. M. Aguilera, C. M. Yu, M. Marijianowski, et al.
Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF)
Eur J Heart Fail,
September 1, 2008;
10(9):
907 - 916.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. G. J. Gademan, R. J. van Bommel, C. Ypenburg, J. C. W. Haest, M. J. Schalij, E. E. van der Wall, J. J. Bax, and C. A. Swenne
Biventricular pacing in chronic heart failure acutely facilitates the arterial baroreflex
Am J Physiol Heart Circ Physiol,
August 1, 2008;
295(2):
H755 - H760.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. K. Lahiri, P. J. Kannankeril, and J. J. Goldberger
Assessment of Autonomic Function in Cardiovascular Disease: Physiological Basis and Prognostic Implications
J. Am. Coll. Cardiol.,
May 6, 2008;
51(18):
1725 - 1733.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Burri, H. Sunthorn, A. Somsen, E. Fleury, C. Stettler, D. Shah, and A. Righetti
Improvement in cardiac sympathetic nerve activity in responders to resynchronization therapy
Europace,
March 1, 2008;
10(3):
374 - 378.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Fantoni, F. Regoli, A. Ghanem, S. Raffa, C. Klersy, A. Sorgente, F. Faletra, M. Baravelli, L. Inglese, J. A. Salerno-Uriarte, et al.
Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy
Eur J Heart Fail,
March 1, 2008;
10(3):
298 - 307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Europace,
October 1, 2007;
9(10):
959 - 998.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Eur. Heart J.,
September 2, 2007;
28(18):
2256 - 2295.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Arena, J. Myers, M. A. Williams, M. Gulati, P. Kligfield, G. J. Balady, E. Collins, and G. Fletcher
Assessment of Functional Capacity in Clinical and Research Settings: A Scientific Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing
Circulation,
July 17, 2007;
116(3):
329 - 343.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Auricchio and M. T. Rovere
Reply
J. Am. Coll. Cardiol.,
September 19, 2006;
48(6):
1286 - 1286.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Raj, D. E. Roach, M. L. Koshman, and R. S. Sheldon
Standard Deviation of Sequential Five-Minute R-R Interval Means (SDANN) Is a Prognostic Marker, but Not Necessarily an Autonomic Marker
J. Am. Coll. Cardiol.,
September 19, 2006;
48(6):
1285 - 1286.
[Full Text]
[PDF]
|
|
|
|
